Tirzepatide is a groundbreaking therapeutic agent for individuals battling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) https://murraysjpf204994.p2blogs.com/39015261/tirzepatide-a-game-changer-for-type-2-diabetes